home.social

#antibody — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #antibody, aggregated by home.social.

  1. AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos

    AstraZeneca is investing $2 billion in Summit Therapeutics to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #antibody-drugconjugates #biotech #Deals #drugcombinations #FierceBiotechHomepage #FiercePharmaHomepage #PD-1 #SummitTherapeutics #VEGF
    europesays.com/britain/133635/

  2. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  3. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  4. This Startup Is Using to Fight Off a Future AI
    is using to design for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  5. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http

  6. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http